Saiyad Bastaminejad

Dr. Saiyad Bastaminejad


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2017 in Iranian Biomedical Journal
Verified
Journal Article
Open access
PDF file
SBSaiyad Bastaminejad
Saiyad Bastaminejad
MTMorovat Taherikalani
Morovat Taherikalani
RGReza Ghanbari
Reza Ghanbari
AAAkbar Akbari
Akbar Akbari
NSNooshin Shabab
Nooshin Shabab
MSMassoud Saidijam
Massoud Saidijam
Background: Most cancer studies focus on exploring non-invasive biomarkers for cancer detection. In the present study, we sought to investigate the expression level of microRNA-21 (miR-21), as a potential diagnostic marker, in serum and stool samples from 40 patients with colorectal cancer (CRC) and 40 healthy controls. Methods: Quantitative real-time RT-PCR ...



18 August 2023 in Research Square
Verified
Preprint
Open access
PDF file
MKMaryam Khedrimirghaed
Maryam Khedrimirghaed
HGHori Ghaneialvar
Hori Ghaneialvar
AMAliashraf Mozafari
Aliashraf Mozafari
MHMohammad Amin Heidari
Mohammad Amin Heidari
SBSaiyad Bastaminejad
Saiyad Bastaminejad
Background Diabetic nephropathy is a common complication of diabetes, which can be prevented by early diagnosis and development. The aim of the present study was to evaluate the expression level of miR-192 and miR-377 in serum samples of diabetic subjects without nephropathy and diabetic nephropathy subjects to investigate these miRNAs as a biomarker for the diagnosis and prognosis of diabetic nephropathy. Methods and Results We reviewed 370 patients diagnosed with diabetes mellitus type 2 (T2D) (190 patients with diabetic nephropathy and 180 patients with diabetes without nephropathy), and 170 healthy control individuals without any history of T2D. Expression analysis of miR-192 and miR-377 was performed by Real-Time PCR. The expression level of miR-192 was significantly increased in the diabetic nephropathy and diabetic without nephropathy groups (p < 0.05 and p < 0.01). Also, the expression level of miR-377 was significantly increased in the diabetic group without nephropathy compared to the control group (P < 0.05), although miR-377 expression in the diabetic nephropathy samples was a significant decrease compared with the diabetic without nephropathy samples (P > 0.05). QRT-PCR results showed that the expressions of miR-192 and miR-377 were significantly lower and higher in the diabetic without nephropathy group than in micro-albuminuria and macro-albuminuria groups, respectively. Conclusions Overexpression of miR-192 and down-regulation of miR-377 were observed in diabetic nephropathy. Up-regulation of miR-192 can be used as a prognostic factor for diagnosing diabetic nephropathy.

14 October 2026 in BMC Gastroenterology
Verified
Journal Article
Open access
PDF file
SBSaiyad Bastaminejad
Saiyad Bastaminejad
AAAli Asghari
Ali Asghari
Mohammad Reza MohammadiMohammad Reza Mohammadi
Mohammad Reza Mohammadi
RNRoumina Norouzi
Roumina Norouzi
LNLeila Naseri
Leila Naseri
MPMaryam Kazem Pour
Maryam Kazem Pour
The clinical significance of Blastocystis spp. in irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD) remains uncertain. This study investi

29 October 2026 in Folia Microbiologica
Verified
Journal Article
Closed access
PDF file
SBSaiyad Bastaminejad
Saiyad Bastaminejad
SBSalar Bakhtiyari
Salar Bakhtiyari
AHAmin Heidari
Amin Heidari
EEEsmaeil Ebrahimi
Esmaeil Ebrahimi